Abstract
Type 2 diabetes is a prevalent chronic disease arising as a serious public health problem worldwide. Diet intervention is considered to be a critical strategy in glycemic control of diabetic patients. Recently, the low-carbohydrate ketogenic diet is shown to be effective in glycemic control and weight loss. However, hepatic lipid accumulation could be observed in mice treated with ketogenic diet. On the other hand, exercise is a well-known approach for treating nonalcoholic fatty liver disease. We thus hypothesize that the combination of ketogenic diet and exercise could improve insulin sensitivity, while minimizing adverse effect of hepatic steatosis. In order to test this hypothesis, we established diabetic mice model with streptozotocin (STZ) and divided them into control group, ketogenic diet group, and ketogenic diet with aerobic exercise group. We found that after six weeks of intervention, mice treated with ketogenic diet and ketogenic diet combined with exercise both have lower body weights, HbAlc level, HOMA index, and improvements in insulin sensitivity, compared with diabetes group. In addition, mice in ketogenic diet intervention exhibited hepatic steatosis shown by serum and hepatic parameters, as well as histochemistry staining in the liver, which could be largely relieved by exercise. Furthermore, gene analysis revealed that ketogenic diet in combination with exercise reduced PPARγ and lipid synthetic genes, as well as enhancing PPARα and lipid β-oxidation gene program in the liver compared to those in ketogenic diet without exercise. Overall, the present study demonstrated that the combination of ketogenic diet and a moderate-intensity aerobic exercise intervention improved insulin sensitivity in diabetic mice, while avoiding hepatic steatosis, which provided a novel strategy in the combat of diabetes.
Highlights
Type 2 diabetes (T2D) has become a worldwide epidemic that affected over 422 million people in 2014 according to the World Health Organization
After 6-week intervention, we found that diabetic mice in ketogenic diet intervention significantly improved insulin sensitivity while exhibiting hepatic steatosis, which could be largely relieved by aerobic exercise
Blood glycosylated hemoglobin (HbA1c) levels and serum glucose and insulin levels were reduced significantly in mice treated with ketogenic diet and ketogenic diet (Figures 2(d)–2(f))
Summary
Type 2 diabetes (T2D) has become a worldwide epidemic that affected over 422 million people in 2014 according to the World Health Organization. Due to the increased rates of hepatic gluconeogenesis, and the insulin resistance are the hallmark of T2D, while the current treatment is ineffective [3, 10, 11]. Antidiabetic drugs, such as thiazolidinedione and metformin, have been widely used in treating T2D, a growing number of nondrug therapies have spread with. A very low-carbohydrate/high-fat diet (ketogenic diet, KD) is one of the most used dietary therapies for patients with diabetes or obesity in recent clinical studies [14,15,16]. Previous studies reported that the ketogenic diet contributed to weight loss in diet-induced obese patients as well as improving glycemic control and metabolic parameters in type 2 diabetes [18,19,20,21,22]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have